Literature DB >> 24623855

Derivation of naive human embryonic stem cells.

Carol B Ware1, Angelique M Nelson, Brigham Mecham, Jennifer Hesson, Wenyu Zhou, Erica C Jonlin, Antonio J Jimenez-Caliani, Xinxian Deng, Christopher Cavanaugh, Savannah Cook, Paul J Tesar, Jeffrey Okada, Lilyana Margaretha, Henrik Sperber, Michael Choi, C Anthony Blau, Piper M Treuting, R David Hawkins, Vincenzo Cirulli, Hannele Ruohola-Baker.   

Abstract

The naïve pluripotent state has been shown in mice to lead to broad and more robust developmental potential relative to primed mouse epiblast cells. The human naïve ES cell state has eluded derivation without the use of transgenes, and forced expression of OCT4, KLF4, and KLF2 allows maintenance of human cells in a naïve state [Hanna J, et al. (2010) Proc Natl Acad Sci USA 107(20):9222-9227]. We describe two routes to generate nontransgenic naïve human ES cells (hESCs). The first is by reverse toggling of preexisting primed hESC lines by preculture in the histone deacetylase inhibitors butyrate and suberoylanilide hydroxamic acid, followed by culture in MEK/ERK and GSK3 inhibitors (2i) with FGF2. The second route is by direct derivation from a human embryo in 2i with FGF2. We show that human naïve cells meet mouse criteria for the naïve state by growth characteristics, antibody labeling profile, gene expression, X-inactivation profile, mitochondrial morphology, microRNA profile and development in the context of teratomas. hESCs can exist in a naïve state without the need for transgenes. Direct derivation is an elusive, but attainable, process, leading to cells at the earliest stage of in vitro pluripotency described for humans. Reverse toggling of primed cells to naïve is efficient and reproducible.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24623855      PMCID: PMC3970494          DOI: 10.1073/pnas.1319738111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Optimization of minuscule samples for use with cDNA microarrays.

Authors:  Susan McLean Hunter; Fiona C Mansergh; Martin J Evans
Journal:  J Biochem Biophys Methods       Date:  2007-12-23

2.  Derivation of novel human ground state naive pluripotent stem cells.

Authors:  Ohad Gafni; Leehee Weinberger; Abed AlFatah Mansour; Yair S Manor; Elad Chomsky; Dalit Ben-Yosef; Yael Kalma; Sergey Viukov; Itay Maza; Asaf Zviran; Yoach Rais; Zohar Shipony; Zohar Mukamel; Vladislav Krupalnik; Mirie Zerbib; Shay Geula; Inbal Caspi; Dan Schneir; Tamar Shwartz; Shlomit Gilad; Daniela Amann-Zalcenstein; Sima Benjamin; Ido Amit; Amos Tanay; Rada Massarwa; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

3.  Derivation of embryonic stem cell lines.

Authors:  S J Abbondanzo; I Gadi; C L Stewart
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

4.  New cell lines from mouse epiblast share defining features with human embryonic stem cells.

Authors:  Paul J Tesar; Josh G Chenoweth; Frances A Brook; Timothy J Davies; Edward P Evans; David L Mack; Richard L Gardner; Ronald D G McKay
Journal:  Nature       Date:  2007-06-27       Impact factor: 49.962

5.  Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.

Authors:  Carol B Ware; Linlin Wang; Brigham H Mecham; Lanlan Shen; Angelique M Nelson; Merav Bar; Deepak A Lamba; Derek S Dauphin; Brian Buckingham; Bardia Askari; Raymond Lim; Muneesh Tewari; Stanley M Gartler; Jean-Pierre Issa; Paul Pavlidis; Zhijun Duan; C Anthony Blau
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

6.  Recognition of the neural chemoattractant Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration.

Authors:  Mayra Yebra; Anthony M P Montgomery; Giuseppe R Diaferia; Thomas Kaido; Steve Silletti; Brandon Perez; Margaret L Just; Simone Hildbrand; Rosemary Hurford; Elin Florkiewicz; Marc Tessier-Lavigne; Vincenzo Cirulli
Journal:  Dev Cell       Date:  2003-11       Impact factor: 12.270

7.  Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance.

Authors:  Chun-Wun Lu; Shih-Chieh Lin; Ko-Fan Chen; Yen-Yu Lai; Shaw-Jenq Tsai
Journal:  J Biol Chem       Date:  2008-08-21       Impact factor: 5.157

8.  The ground state of embryonic stem cell self-renewal.

Authors:  Qi-Long Ying; Jason Wray; Jennifer Nichols; Laura Batlle-Morera; Bradley Doble; James Woodgett; Philip Cohen; Austin Smith
Journal:  Nature       Date:  2008-05-22       Impact factor: 49.962

9.  MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells.

Authors:  Jiaqiang Ren; Ping Jin; Ena Wang; Francesco M Marincola; David F Stroncek
Journal:  J Transl Med       Date:  2009-03-23       Impact factor: 5.531

10.  Derivation of pluripotent epiblast stem cells from mammalian embryos.

Authors:  I Gabrielle M Brons; Lucy E Smithers; Matthew W B Trotter; Peter Rugg-Gunn; Bowen Sun; Susana M Chuva de Sousa Lopes; Sarah K Howlett; Amanda Clarkson; Lars Ahrlund-Richter; Roger A Pedersen; Ludovic Vallier
Journal:  Nature       Date:  2007-06-27       Impact factor: 49.962

View more
  201 in total

Review 1.  Present and future challenges of induced pluripotent stem cells.

Authors:  Mari Ohnuki; Kazutoshi Takahashi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 2.  Hallmarks of pluripotency.

Authors:  Alejandro De Los Angeles; Francesco Ferrari; Ruibin Xi; Yuko Fujiwara; Nissim Benvenisty; Hongkui Deng; Konrad Hochedlinger; Rudolf Jaenisch; Soohyun Lee; Harry G Leitch; M William Lensch; Ernesto Lujan; Duanqing Pei; Janet Rossant; Marius Wernig; Peter J Park; George Q Daley
Journal:  Nature       Date:  2015-09-24       Impact factor: 49.962

Review 3.  Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons.

Authors:  Aaron B Bradford; Patrick M McNutt
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

Review 4.  Deconstructing and reconstructing the mouse and human early embryo.

Authors:  Marta N Shahbazi; Magdalena Zernicka-Goetz
Journal:  Nat Cell Biol       Date:  2018-07-23       Impact factor: 28.824

5.  Comprehensive Mapping of Pluripotent Stem Cell Metabolism Using Dynamic Genome-Scale Network Modeling.

Authors:  Sriram Chandrasekaran; Jin Zhang; Zhen Sun; Li Zhang; Christian A Ross; Yu-Chung Huang; John M Asara; Hu Li; George Q Daley; James J Collins
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

Review 6.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

Review 7.  Concise Review: Lessons from Naïve Human Pluripotent Cells.

Authors:  Carol B Ware
Journal:  Stem Cells       Date:  2016-11-10       Impact factor: 6.277

8.  Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Jeffrey S Huo; Karan Verma; Sarshan R Pather; C Conover Talbot; Jasmin Agarwal; Diana Steppan; Yang W Zhang; Michael Considine; Hong Guo; Xiufeng Zhong; Christian Gutierrez; Leslie Cope; M Valeria Canto-Soler; Alan D Friedman; Stephen B Baylin; Elias T Zambidis
Journal:  Development       Date:  2016-09-22       Impact factor: 6.868

9.  Wnt/β-catenin signaling promotes self-renewal and inhibits the primed state transition in naïve human embryonic stem cells.

Authors:  Zhuojin Xu; Aaron M Robitaille; Jason D Berndt; Kathryn C Davidson; Karin A Fischer; Julie Mathieu; Jennifer C Potter; Hannele Ruohola-Baker; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

Review 10.  Searching for naïve human pluripotent stem cells.

Authors:  Simone Aparecida Siqueira Fonseca; Roberta Montero Costas; Lygia Veiga Pereira
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.